FDA discusses the most common labeling mistakes found in Abbreviated New Drug Applications (ANDAs) and how to avoid them. FDA will also provide answers to common labeling questions asked by generic drug applicants.
Learn more at [ Ссылка ]
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - [ Ссылка ]
SBIA Listserv - [ Ссылка ]
SBIA 2021 Playlist - [ Ссылка ]
SBIA LinkedIn: [ Ссылка ]
SBIA Training Resources - [ Ссылка ]
Twitter - [ Ссылка ]
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
![](https://s2.save4k.ru/pic/CQIqMSte07M/maxresdefault.jpg)